We are live on ! Find out more
KYMR icon

Kymera Therapeutics
KYMR

136 hedge funds and large institutions have $1.55B invested in Kymera Therapeutics in 2023 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 36 increasing their positions, 53 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

354% more call options, than puts

Call options by funds: $1.97M | Put options by funds: $433K

100% more funds holding in top 10

Funds holding in top 10: 3 → 6 (+3)

94% more capital invested

Capital invested by funds: $797M → $1.55B (+$753M)

83% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 18

12% more funds holding

Funds holding: 121 → 136 (+15)

6.24% more ownership

Funds ownership: 103.5% → 109.74% (+6.2%)

32% less repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 53

Holders
136
Holders Change
+15
Holders Change %
+12.4%
% of All Funds
1.98%
Holding in Top 10
6
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+100%
% of All Funds
0.09%
New
33
Increased
36
Reduced
53
Closed
18
Calls
$1.97M
Puts
$433K
Net Calls
+$1.53M
Net Calls Change
+$913K

Top Buyers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
+$22.3M
2
AG
Artal Group
Luxembourg
+$13M
3
Morgan Stanley
Morgan Stanley
New York
+$9.71M
4
Goldman Sachs
Goldman Sachs
New York
+$8.4M
5
SSA
Schonfeld Strategic Advisors
New York
+$7.83M

Top Sellers

Rank Fund Capital Flow
1
WA
Wasatch Advisors
Utah
-$7.96M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$6.01M
3
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
-$5.63M
4
American Century Companies
American Century Companies
Missouri
-$3.79M
5
CS
Candriam SCA
Luxembourg
-$2.59M
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
26
Citadel Advisors
Florida
$9.46M +$2.73M +152,460 +70%
Northern Trust
27
Northern Trust
Illinois
$9.13M -$137K -7,676 -2%
CS
28
Candriam SCA
Luxembourg
$8.74M -$2.59M -145,004 -30%
Charles Schwab
29
Charles Schwab
California
$7.81M +$88.5K +4,951 +2%
UBS Group
30
UBS Group
Switzerland
$7.65M +$2.46M +137,704 +85%
Voloridge Investment Management
31
Voloridge Investment Management
Florida
$6.16M +$2.06M +114,983 +91%
TI
32
Trexquant Investment
Connecticut
$5.18M +$3.64M +203,564 New
Jane Street
33
Jane Street
New York
$4.99M +$1.73M +96,915 +98%
TD Asset Management
34
TD Asset Management
Ontario, Canada
$4.75M +$42.9K +2,400 +1%
Schroder Investment Management Group
35
Schroder Investment Management Group
United Kingdom
$4.72M -$756K -42,281 -19%
UBS AM
36
UBS AM
Illinois
$4.49M -$237K -13,233 -7%
Two Sigma Advisers
37
Two Sigma Advisers
New York
$4.35M -$315K -17,600 -9%
CS
38
Credit Suisse
Switzerland
$4.18M +$2.27M +126,822 +340%
N
39
Nuveen
North Carolina
$3.48M +$750K +41,962 +44%
Bank of New York Mellon
40
Bank of New York Mellon
New York
$3.4M +$131K +7,327 +6%
Two Sigma Investments
41
Two Sigma Investments
New York
$3.38M -$1.69M -94,675 -42%
Neuberger Berman Group
42
Neuberger Berman Group
New York
$3.08M +$2.17M +121,079 New
Rafferty Asset Management
43
Rafferty Asset Management
New York
$3.06M -$535K -29,910 -20%
HF
44
HRT Financial
New York
$2.73M +$1.92M +107,307 New
WP
45
Woodline Partners
California
$2.57M -$43.6K -2,438 -2%
Manulife (Manufacturers Life Insurance)
46
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2.55M +$413K +23,093 +30%
AG
47
Algert Global
California
$2.53M -$521K -29,160 -23%
Millennium Management
48
Millennium Management
New York
$2.5M -$1.32M -73,615 -43%
CSS
49
Cubist Systematic Strategies
Connecticut
$2.43M +$1.71M +95,580 New
Citigroup
50
Citigroup
New York
$2.26M -$212K -11,867 -12%
1
2
3 4 5

KYMR Hedge Fund Activity: Q4 2023 in Review

136 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Kymera Therapeutics (KYMR) for Q4 2023, worth a combined $1.55B — up 94% from $797M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new KYMR positions and 18 closed out — a net gain of 15 holders — while 36 added to existing stakes and 53 trimmed.

The largest buyer was Baker Bros. Advisors, adding an estimated $22.3M. The largest seller was Wasatch Advisors, exiting entirely with an estimated $7.96M sold.

  • 136 institutional investors held Kymera Therapeutics (KYMR) as of Q4 2023, up from 121 in Q3 2023.
  • Funds reported $1.55B of Kymera Therapeutics stock for Q4 2023, up 94% quarter-over-quarter.
  • 33 funds opened new Kymera Therapeutics positions in Q4 2023 and 18 closed out, a net change of +15 holders.
  • The largest Kymera Therapeutics buyer in Q4 2023 was Baker Bros. Advisors, an estimated $22.3M added.
  • The largest Kymera Therapeutics seller in Q4 2023 was Wasatch Advisors, an estimated $7.96M sold.

Based on aggregated 13F filings for Q4 2023.